Nejvíce citovaný článek - PubMed ID 28713266
Significance of Microbiota in Obesity and Metabolic Diseases and the Modulatory Potential by Medicinal Plant and Food Ingredients
In the current study, pyroglutamic acid (pGlu), a natural amino acid derivative, has efficiently inhibited the catalytic activities of three important enzymes, namely: Human recombinant phosphodiesterase-5A1 (PDE5A1), human angiotensin-converting enzyme (ACE), and urease. These enzymes were reported to be associated with several important clinical conditions in humans. Radioactivity-based assay, spectrophotometric-based assay, and an Electrospray Ionization-Mass Spectrometry-based method were employed to ascertain the inhibitory actions of pGlu against PDE5A1, ACE, and urease, respectively. The results unveiled that pGlu potently suppressed the activity of PDE5A1 (half-maximal inhibitory concentration; IC50 = 5.23 µM) compared with that of standard drug sildenafil citrate (IC50 = 7.14 µM). Moreover, pGlu at a concentration of 20 µg/mL was found to efficiently inhibit human ACE with 98.2% inhibition compared with that of standard captopril (99.6%; 20 µg/mL). The urease-catalyzed reaction was also remarkably inactivated by pGlu and standard acetohydroxamic acid with IC50 values of 1.8 and 3.9 µM, respectively. Remarkably, the outcome of in vitro cytotoxicity assay did not reveal any significant cytotoxic properties of pGlu against human cervical carcinoma cells and normal human fetal lung fibroblast cells. In addition to in vitro assays, molecular docking analyses were performed to corroborate the outcomes of in vitro results with predicted structure-activity relationships. In conclusion, pGlu could be presented as a natural and multifunctional agent with promising applications in the treatment of some ailments connected with the above-mentioned anti-enzymatic properties.
- Klíčová slova
- ESI-mass spectrometry, angiotensin-converting enzyme, anti-enzymatic properties, cytotoxicity, phosphodiesterase 5, pyroglutamic acid, urease,
- MeSH
- angiotensin konvertující enzym chemie genetika metabolismus MeSH
- buněčné linie MeSH
- cyklické nukleotidfosfodiesterasy, typ 5 chemie genetika metabolismus MeSH
- hmotnostní spektrometrie s elektrosprejovou ionizací MeSH
- inhibiční koncentrace 50 MeSH
- kaptopril chemie metabolismus MeSH
- kyselina pyrrolidonkarboxylová chemie metabolismus toxicita MeSH
- kyseliny hydroxamové antagonisté a inhibitory metabolismus MeSH
- lidé MeSH
- rekombinantní proteiny biosyntéza chemie izolace a purifikace MeSH
- sildenafil citrát chemie metabolismus MeSH
- simulace molekulového dockingu MeSH
- spektrofotometrie MeSH
- terciární struktura proteinů MeSH
- ureasa antagonisté a inhibitory metabolismus MeSH
- vazebná místa MeSH
- viabilita buněk účinky léků MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- ACE protein, human MeSH Prohlížeč
- acetohydroxamic acid MeSH Prohlížeč
- angiotensin konvertující enzym MeSH
- cyklické nukleotidfosfodiesterasy, typ 5 MeSH
- kaptopril MeSH
- kyselina pyrrolidonkarboxylová MeSH
- kyseliny hydroxamové MeSH
- PDE5A protein, human MeSH Prohlížeč
- rekombinantní proteiny MeSH
- sildenafil citrát MeSH
- ureasa MeSH